Vinva Investment Management Ltd Has $2.62 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Vinva Investment Management Ltd boosted its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 19.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 12,434 shares of the financial services provider’s stock after buying an additional 1,991 shares during the quarter. Vinva Investment Management Ltd’s holdings in CME Group were worth $2,624,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CME. Gold Investment Management Ltd. bought a new stake in CME Group in the fourth quarter valued at approximately $26,000. Northwest Financial Advisors bought a new position in CME Group during the fourth quarter worth $28,000. Harbor Investment Advisory LLC raised its position in shares of CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 145 shares during the period. BKM Wealth Management LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $38,000. Finally, Atticus Wealth Management LLC bought a new stake in shares of CME Group during the 3rd quarter worth about $40,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on CME shares. JPMorgan Chase & Co. lifted their price target on CME Group from $198.00 to $206.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. Rosenblatt Securities reiterated a “sell” rating and issued a $187.00 price objective (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Morgan Stanley boosted their price target on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. Finally, Barclays raised their price objective on CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $217.80.

View Our Latest Research Report on CME Group

Insider Buying and Selling

In related news, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the sale, the director now directly owns 14,008 shares in the company, valued at $2,821,771.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Elizabeth A. Cook sold 1,000 shares of the company’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $211.52, for a total transaction of $211,520.00. Following the sale, the director now owns 18,241 shares in the company, valued at approximately $3,858,336.32. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The disclosure for this sale can be found here. Insiders have sold a total of 51,290 shares of company stock valued at $10,807,380 over the last 90 days. 0.30% of the stock is owned by insiders.

CME Group Price Performance

CME stock traded down $0.97 during midday trading on Friday, reaching $199.36. 1,886,162 shares of the stock were exchanged, compared to its average volume of 1,795,671. CME Group Inc. has a 52 week low of $177.04 and a 52 week high of $223.80. The company has a fifty day moving average price of $209.66 and a 200 day moving average price of $210.71. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $71.78 billion, a PE ratio of 22.68, a P/E/G ratio of 5.33 and a beta of 0.52.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter in the prior year, the firm posted $2.42 earnings per share. The firm’s revenue was up 3.2% compared to the same quarter last year. As a group, analysts expect that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be issued a dividend of $1.15 per share. The ex-dividend date is Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.31%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.